Selective toxicity is critical in cancer therapy; to determine whether the MNS1 compounds selectively killed cancer cells with minimal toxicity to normal brain cells, we tested the MNS1 compounds with treatments ranging from 0.01–25 μM. The gene discussed is MNS1; the disease is cancer.